ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

TNXP Tonix Pharmaceuticals Holding Corporation

0.56
-0.0195 (-3.36%)
27 7월(7) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Tonix Pharmaceuticals Holding Corporation TNXP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0195 -3.36% 0.56 08:50:05
개장가 저가 고가 종가 전일 종가
0.5512 0.54 0.566561 0.55 0.5795
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/07/202421:06EDGAR2Form 8-K - Current report
25/07/202421:00GLOBETonix Pharmaceuticals Granted Fast Track Designation by FDA..
25/07/202406:14EDGAR2Form 8-K/A - Current report: [Amend]
16/07/202422:12EDGAR2Form 8-K - Current report
11/07/202405:48EDGAR2Form 8-K - Current report
11/07/202405:30GLOBETonix Pharmaceuticals Announces Closing of $4.0 Million..
10/07/202405:33EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/07/202422:15GLOBETonix Pharmaceuticals Announces Pricing of Approximately..
09/07/202406:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/07/202406:00GLOBETonix Pharmaceuticals Announces Proposed Public Offering
08/07/202421:05EDGAR2Form 8-K - Current report
08/07/202421:00GLOBETonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting..
01/07/202421:00GLOBETonix Pharmaceuticals Awarded Up to $34 Million U.S...
29/06/202405:05GLOBETonix Pharmaceuticals Announces Closing of $4.0 Million..
27/06/202421:36GLOBETonix Pharmaceuticals Announces Pricing of Approximately..
27/06/202405:40GLOBETonix Pharmaceuticals Announces Proposed Public Offering
27/06/202404:13GLOBETonix Pharmaceuticals Regains Compliance with Nasdaq Minimum..
25/06/202421:00GLOBETonix Pharmaceuticals Presents Vaccine Platform Data in..
20/06/202421:05EDGAR2Form 8-K - Current report
20/06/202421:00GLOBETonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting..
18/06/202421:00GLOBETonix Pharmaceuticals Presented Data Comparing Real-World..
17/06/202421:00GLOBETonix Pharmaceuticals Presented Poster of Tonmya™ for the..
15/06/202406:25EDGAR2Form 8-K/A - Current report: [Amend]
14/06/202406:24EDGAR2Form 8-K - Current report
14/06/202406:00GLOBETonix Pharmaceuticals Announces Closing of $4.0 Million..
13/06/202406:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202422:00GLOBETonix Pharmaceuticals Announces Pricing of $4.0 Million..
12/06/202406:17GLOBETonix Pharmaceuticals Announces Proposed Public Offering
12/06/202405:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/06/202421:53EDGAR2Form 8-K - Current report
07/06/202400:21EDGAR2Form 8-K - Current report
07/06/202400:00GLOBETonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
06/06/202421:05EDGAR2Form 8-K - Current report
06/06/202421:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
05/06/202421:00GLOBETonix Pharmaceuticals Announces Poster Presentation at the..
03/06/202421:05EDGAR2Form 8-K - Current report
03/06/202421:00GLOBETonix Pharmaceuticals Presented New Data on Tonmya™..
30/05/202421:05EDGAR2Form 8-K - Current report
30/05/202421:00GLOBETonix Pharmaceuticals Announces Two Poster Presentations of..
29/05/202421:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
28/05/202421:00GLOBETonix Pharmaceuticals Announces Presentation at the 2024 BIO..
25/05/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/05/202406:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/05/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/05/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/05/202406:16EDGAR2Form 8-K - Current report
22/05/202421:05EDGAR2Form 8-K - Current report
22/05/202421:00GLOBETonix Pharmaceuticals to Deliver an Oral Presentation and..
21/05/202421:07EDGAR2Form 8-K - Current report
21/05/202421:00GLOBETonix Pharmaceuticals Announces Key Findings from Initial..